Taxotere lawsuit plaintiffs will now be able to file their hair loss cases directly in the federal litigation underway in the U.S. District Court, Eastern District of Louisiana. According to an Order dated on December 9th, direct filing will eliminate … Continue reading
Pennsylvania’s sixth trial of a Risperdal gynecomastia lawsuit came to an abrupt end on Tuesday, after the judge overseeing the case granted Janssen Pharmaceutical’s motion for compulsory nonsuit. According to a report from The Legal Intelligencer, Philadelphia Court of Common … Continue reading
The federal litigation that currently houses dozens of Johnson & Johnson talcum powder lawsuits has begun to move forward. A Case Management Order recently issued by the U.S. District Court, District of New Jersey, indicates that a “Science Day” will … Continue reading
Bristol-Myers Squibb has agreed to a $19.5 million Abilify settlement that resolves allegations that it improperly marketed the antipsychotic drug for use in elderly dementia patients. The company has also agreed to restrict its marketing of other medications that contain … Continue reading
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has agreed to centralize all federally-filed hernia mesh lawsuits involving Atrium Medical Corp.’s C-Qur surgical mesh. Currently pending cases, as well as any future federal C-Qur lawsuits, will now be transferred to … Continue reading
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has centralized all federally-filed Invokana lawsuits in the U.S. District Court, District of New Jersey. However, the new proceeding will not include product liability claims involving other Type 2 diabetes drugs in … Continue reading
A new hernia mesh lawsuit filed last month in Massachusetts federal court claims that a patient sustained severe injuries due to Ethicon, Inc.’s Physiomesh Flexible Composite Mesh hernia patch. The complaint accuses Ethicon of manufacturing a faulty device, and asserts … Continue reading
Health regulators in Europe have issued a new warning regarding the potential for direct-acting antiviral Hepatitis C medications to reactivate a latent Hepatitis B virus. According to December 2nd communication issued by the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee … Continue reading
Johnson & Johnson’s DePuy Orthopaedics subsidiary has been ordered to pay a combined $1.04 billion to six individuals who suffered serious complications associated with a metal-on-metal version of the Pinnacle Hip Replacement System. According to court documents, jurors agreed with … Continue reading